These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 12763125)
21. The use of atosiban and ritodrine in external cephalic version. Stergiotou I; Talbot F; Yoong W Acta Obstet Gynecol Scand; 2007; 86(8):927-9. PubMed ID: 17653876 [TBL] [Abstract][Full Text] [Related]
22. Oxytocin antagonists for tocolysis in preterm labour -- a systematic review. Coomarasamy A; Knox EM; Gee H; Khan KS Med Sci Monit; 2002 Nov; 8(11):RA268-73. PubMed ID: 12444392 [TBL] [Abstract][Full Text] [Related]
23. [Clinical experience of using oxytocin antagonist atosiban in the rescue therapy of preterm labour]. Tan JP; Chen H; Du BJ; Liu YL; Wang YH; Zhang JP Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):81-4. PubMed ID: 18683742 [TBL] [Abstract][Full Text] [Related]
24. Clinical practice evaluation of combination of atosiban, ritodrine and ketoprofen for inhibiting preterm labor. Grignaffini A; Soncini E; Ronzoni E; Lo Cane F; Anfuso S; Nardelli GB Minerva Ginecol; 2007 Oct; 59(5):481-9. PubMed ID: 17912174 [TBL] [Abstract][Full Text] [Related]
25. Atosiban and nifedipin for the treatment of preterm labor. Kashanian M; Akbarian AR; Soltanzadeh M Int J Gynaecol Obstet; 2005 Oct; 91(1):10-4. PubMed ID: 16043178 [TBL] [Abstract][Full Text] [Related]
26. Atosiban and nifedipine in acute tocolysis: a comparative study. Al-Omari WR; Al-Shammaa HB; Al-Tikriti EM; Ahmed KW Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):129-34. PubMed ID: 16446025 [TBL] [Abstract][Full Text] [Related]
27. Clinical practice evaluation of atosiban in preterm labour management in six European countries. Fallon A; Fallon UB BJOG; 2007 Aug; 114(8):1043; author reply 1043-4. PubMed ID: 17635490 [No Abstract] [Full Text] [Related]
28. The effects of the tocolytics atosiban and nifedipine on fetal movements, heart rate and blood flow. de Heus R; Mulder EJ; Derks JB; Visser GH J Matern Fetal Neonatal Med; 2009 Jun; 22(6):485-90. PubMed ID: 19479644 [TBL] [Abstract][Full Text] [Related]
29. Developments in the pharmacotherapeutic management of spontaneous preterm labor. Kam KY; Lamont RF Expert Opin Pharmacother; 2008 May; 9(7):1153-68. PubMed ID: 18422473 [TBL] [Abstract][Full Text] [Related]
30. The safety of tocolytics used for the inhibition of preterm labour. Lamont CD; Jørgensen JS; Lamont RF Expert Opin Drug Saf; 2016 Sep; 15(9):1163-73. PubMed ID: 27159501 [TBL] [Abstract][Full Text] [Related]
31. Development and clinical experience with the new evidence-based tocolytic atosiban. Husslein P Acta Obstet Gynecol Scand; 2002 Jul; 81(7):633-41. PubMed ID: 12190838 [TBL] [Abstract][Full Text] [Related]
36. [Atosiban treatment for preterm labor--financial considerations and savings by implementing clinical guidelines]. Hadar E; Mansur N; Ambar I; Hod M Harefuah; 2011 Jun; 150(6):502-6, 553. PubMed ID: 21800486 [TBL] [Abstract][Full Text] [Related]
37. [The threat of premature labor: new aspects for management]. Wertz JP; Frising M; Arendt J Bull Soc Sci Med Grand Duche Luxemb; 1998; 135(1):51-8. PubMed ID: 9868833 [TBL] [Abstract][Full Text] [Related]
38. Review of clinical experience with atosiban and the Tractocile Efficacy Assessment Survey in Europe (TREASURE) study protocol. Husslein P; Quartarolo JP Int J Clin Pract; 2003 Mar; 57(2):121-7. PubMed ID: 12661796 [TBL] [Abstract][Full Text] [Related]